Ignite Creation Date:
2025-12-24 @ 3:57 PM
Ignite Modification Date:
2026-01-06 @ 6:04 AM
Study NCT ID:
NCT00306592
Status:
COMPLETED
Last Update Posted:
2017-03-21
First Post:
2006-01-31
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Natalizumab Re-Initiation of Dosing
Sponsor:
Biogen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-03
Start Date Type:
None
Primary Completion Date:
2007-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-02
Completion Date Type:
ACTUAL
First Submit Date:
2006-01-31
First Submit QC Date:
None
Study First Post Date:
2006-03-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2009-06-30
Results First Submit QC Date:
None
Results First Post Date:
2010-01-26
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-02-14
Last Update Post Date:
2017-03-21
Last Update Post Date Type:
ACTUAL